Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Liora Ketchker"'
Autor:
Assi Milwidsky, Shir Frydman, Michal Laufer‐Perl, Ben Sadeh, Orly Sapir, Yoav Granot, Aviram Hochstadt, Liuba Korotetski, Liora Ketchker, Yan Topilsky, Shmuel Banai, Ofer Havakuk
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 1487-1491 (2022)
Abstract Aims Routine, intermittent inotropic therapy (IIT) is still applied in advanced heart failure (HF) patients either as a bridge to definitive treatment or as a mean to improve quality of life (QOL), despite limited evidence to support its' us
Externí odkaz:
https://doaj.org/article/d01d15856b4c4ca498e71be206e07f54
Autor:
Michal Laufer‐Perl, Sapir Sadon, David Zahler, Assi Milwidsky, Ben Sadeh, Orly Sapir, Yoav Granot, Liuba Korotetski, Liora Ketchker, Maayan Rosh, Shmuel Banai, Ofer Havakuk
Publikováno v:
Clinical cardiology. 45(5)
Advanced heart failure (HF) patients usually poorly tolerate guideline-directed HF medical therapy (GDMT) and suffer high rates of morbidity and mortality. The use of continuous inotropes in the outpatient settings is hampered by previous data showin
The Potential Beneficial Effect of Levosimendan in Milrinone-treated Advanced Heart Failure Patients
Autor:
Liora Ketchker, Orly Sapir, Assi Milwidsky, Michal Laufer-Perl, Shir Frydman, Liuba Korotetski, Ofer Havakuk, Yoav Granot, Ben Sadeh, Yan Topilsky, Aviram Hochstadt, Shmuel Banai
Background Routine, short-term use of inotropic agents is still applied in advanced heart failure (HF) patients either as a bridge to definitive treatment or as a mean to improve quality of life, despite the paucity of scientific evidence. Intermitte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a3330cf0ff95284b6381266f754821a
https://doi.org/10.21203/rs.3.rs-251993/v1
https://doi.org/10.21203/rs.3.rs-251993/v1